The Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160.
Department of Biological Chemistry, The John Hopkins School of Medicine, Baltimore, Maryland 21205.
Toxicol Sci. 2018 Apr 1;162(2):599-610. doi: 10.1093/toxsci/kfy002.
Overdose of acetaminophen (APAP) results in acute liver failure. We have investigated the role of a posttranslational modification of proteins called O-GlcNAcylation, where the O-GlcNAc transferase (OGT) adds and O-GlcNAcase (OGA) removes a single β-D-N-acetylglucosamine (O-GlcNAc) moiety, in the pathogenesis of APAP-induced liver injury. Hepatocyte-specific OGT knockout mice (OGT KO), which have reduced O-GlcNAcylation, and wild-type (WT) controls were treated with 300 mg/kg APAP and the development of injury was studied over a time course from 0 to 24 h. OGT KO mice developed significantly lower liver injury as compared with WT mice. Hepatic CYP2E1 activity and glutathione (GSH) depletion following APAP treatment were not different between WT and OGT KO mice. However, replenishment of GSH and induction of GSH biosynthesis genes were significantly faster in the OGT KO mice. Next, male C57BL/6 J mice were treated Thiamet-G (TMG), a specific inhibitor of OGA to induce O-GlcNAcylation, 1.5 h after APAP administration and the development of liver injury was studied over a time course of 0-24 h. TMG-treated mice exhibited significantly higher APAP-induced liver injury. Treatment with TMG did not affect hepatic CYP2E1 levels, GSH depletion, APAP-protein adducts, and APAP-induced mitochondrial damage. However, GSH replenishment and GSH biosynthesis genes were lower in TMG-treated mice after APAP overdose. Taken together, these data indicate that induction in cellular O-GlcNAcylation exacerbates APAP-induced liver injury via dysregulation of hepatic GSH replenishment response.
对乙酰氨基酚(APAP)过量会导致急性肝衰竭。我们研究了一种称为 O-糖基化的蛋白质翻译后修饰的作用,其中 O-糖基转移酶(OGT)添加和 O-糖基水解酶(OGA)去除单个β-D-N-乙酰葡萄糖胺(O-GlcNAc)部分,在 APAP 诱导的肝损伤发病机制中。具有降低 O-GlcNAcylation 的肝细胞特异性 OGT 敲除小鼠(OGT KO)和野生型(WT)对照用 300mg/kg APAP 处理,并在 0 至 24 小时的时间过程中研究损伤的发展。与 WT 小鼠相比,OGT KO 小鼠的肝损伤明显降低。WT 和 OGT KO 小鼠之间,APAP 处理后肝 CYP2E1 活性和谷胱甘肽(GSH)耗竭没有差异。然而,OGT KO 小鼠中的 GSH 补充和 GSH 生物合成基因的诱导更快。接下来,雄性 C57BL/6 J 小鼠在用 TMG(一种特定的 OGA 抑制剂)诱导 O-GlcNAcylation 1.5 小时后接受 APAP 治疗,并在 0-24 小时的时间过程中研究肝损伤的发展。TMG 处理的小鼠表现出明显更高的 APAP 诱导的肝损伤。TMG 处理不影响肝 CYP2E1 水平、GSH 耗竭、APAP-蛋白加合物和 APAP 诱导的线粒体损伤。然而,在 TMG 处理的小鼠中,APAP 过量后 GSH 补充和 GSH 生物合成基因较低。总之,这些数据表明,细胞 O-GlcNAcylation 的诱导通过肝 GSH 补充反应的失调加重 APAP 诱导的肝损伤。